← Back to Search

personalized cessation care for Smoking Cessation

N/A
Waitlist Available
Led By Brenda Cartmel, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening (1 week prior to baseline), 6 weeks, 8 weeks, 3 months, 6 months
Awards & highlights

Study Summary

This trial will test whether two different interventions can help people quit smoking. One intervention will be a personalized message, and the other will be a biofeedback-based intervention.

Eligible Conditions
  • Smoking Cessation
  • Biofeedback

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening (1 week prior to baseline), 6 weeks, 8 weeks, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening (1 week prior to baseline), 6 weeks, 8 weeks, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of cigarettes smoked
Secondary outcome measures
Expired Air
Plasma Bilirubin
Carotenoids
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Standard Care/No Bio FeedbackExperimental Treatment1 Intervention
This arm will consist of those first randomized to be enrolled in the standard care arm and then those enrolled in the non bio feedback arm.
Group II: Standard Care/ Bio FeedbackExperimental Treatment2 Interventions
This arm will consist of those first randomized to be enrolled in the standard care arm and then those enrolled in the bio feedback arm.
Group III: Personalized Care/ No Bio FeedbackExperimental Treatment2 Interventions
This arm will consist of those first randomized to be enrolled in the personalized care arm and then those enrolled in the non bio feedback arm.
Group IV: Personalized Care/ Bio FeedbackExperimental Treatment2 Interventions
This arm will consist of those first randomized to be enrolled in the personalized care arm and then those enrolled in the bio feedback arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
bio feedback
2016
N/A
~280
personalized cessation care
2016
N/A
~280

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,851 Previous Clinical Trials
2,737,937 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,662 Previous Clinical Trials
40,925,605 Total Patients Enrolled
Brenda Cartmel, PhDPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any enrollment opportunities available for this research study?

"Clinicaltrials.gov reveals that, while this medical trial has been listed since January 1st 2016 and last modified on May 19th 2022, it is not currently recruiting any participants. However, there are 146 other clinical trials seeking patients at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)
2016. "Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02658032.
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top